Axitinib
Brand name: Inlyta
Rank #150 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$109.1M
Total Cost
5,937
Total Claims
$109.1M
Total Cost
317
Prescribers
$18K
Cost per Claim
33
Beneficiaries
5,959
30-Day Fills
$344K
Avg Cost/Provider
19
Avg Claims/Provider
Share of Medicare Part D Spending
0.04%
of total Medicare Part D spending
$109.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $109.1M total
🔎 Data Overview
At $18,371 per prescription, this is a high-cost medication. Expensive drugs drive Medicare spending growth and create access challenges for patients with coverage gaps.
Average cost of $344,068 per prescriber suggests this drug may be concentrated among specialists. High per-provider spending can sometimes indicate inappropriate prescribing or overly aggressive use.
Average cost of $3,305,138 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Axitinib
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Moshe Ornstein | Hematology-Oncology | Cleveland, OH | 60 | $1.3M |
| 2 | Adanma Anji Ayanambakkam Attanathi | Hematology-Oncology | Oklahoma City, OK | 71 | $1.2M |
| 3 | Brian Rini | Hematology-Oncology | Nashville, TN | 50 | $1.0M |
| 4 | Theodore Gourdin | Hematology-Oncology | Charleston, SC | 62 | $1.0M |
| 5 | Thomas Sneed | Hematology-Oncology | Little Rock, AR | 49 | $1.0M |
| 6 | Kathryn Beckermann | Hematology-Oncology | Nashville, TN | 43 | $943K |
| 7 | Rubina Qamar | Medical Oncology | Milwaukee, WI | 47 | $871K |
| 8 | Robert Alter | Hematology-Oncology | Hackensack, NJ | 46 | $856K |
| 9 | Mayer Fishman | Hematology-Oncology | Tampa, FL | 37 | $837K |
| 10 | Aihua Yen | Hematology-Oncology | Houston, TX | 43 | $836K |
| 11 | Scott Cole | Medical Oncology | Tulsa, OK | 41 | $832K |
| 12 | Michael Hurwitz | Medical Oncology | New Haven, CT | 45 | $830K |
| 13 | Susan Roethke | Nurse Practitioner | Phila, PA | 40 | $809K |
| 14 | Samuel Wood | Hematology-Oncology | Cedar Rapids, IA | 36 | $802K |
| 15 | Susan Sargent | Nurse Practitioner | Rochester, NY | 38 | $787K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 147 | Dimethyl Fumarate (Dimethyl Fumarate) | $109.8M | 29,208 |
| 148 | Immun Glob G(Igg)/Gly/Iga 0-50 (Gammaplex) | $109.6M | 7,815 |
| 149 | Mesalamine (Mesalamine) | $109.3M | 176,079 |
| 150 | Axitinib (Inlyta) | $109.1M | 5,937 |
| 151 | Ipratropium/Albuterol Sulfate (Combivent Respimat) | $108.3M | 353,594 |
| 152 | Relugolix (Orgovyx) | $107.3M | 38,821 |
| 153 | Pen Needle, Diabetic (Ultra-Fine Mini Pen Needle) | $105.0M | 1,305,150 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology